Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

The prevalence and absolute counts of peripheral blood Lymphocyte subsets. by Songyan Zou (11399489)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

BFD2 regulates anxiety-like behaviors induced by acute-stage <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

BFD2 impacts pre-anxiety-like behaviors in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

BFD2 exacerbates the inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

BFD2 mediates brain inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

The CONSORT flow diagram. by Anneli Peolsson (7867601)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups. by Anneli Peolsson (7867601)

Subjects:

Baseline descriptive characteristics of trial participants with dizziness, by treatment group. by Anneli Peolsson (7867601)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3. by Anneli Peolsson (7867601)

Subjects:

ELISA results in serum indices between the control and diarrhea groups. by Houkang Ding (20968091)

Subjects:

Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness. by Anneli Peolsson (7867601)

Subjects:

Relative abundance of microbiota in colonic content at the genus level (n =  5). by Houkang Ding (20968091)

Subjects:

Potential metabolites in the colonic tissue related with diarrhea induced by FSE. by Houkang Ding (20968091)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each WAD group, and within-group effects. by Anneli Peolsson (7867601)

Subjects: